Quinidex Articles
AVANIR stock rockets on positive Ph III Zenvia data
12 August 2009
Positive PK data on Avanir's Zenvia
9 June 2008
Avanir's Neurodex sees strong Ph III data
8 May 2006
FDA accepts AVANIR's Neurodex for priority review
10 April 2006
Florida moves on five neg formulary drugs
26 January 2001
FDA backs Pfizer's dofetilide, launch slated for early 2000
11 October 1999
FDA recommends approval of Pfizer's Tikosyn
3 February 1999
Russian Drug Output Fails To Meet Demand
27 January 1997
quinidine warning label discussion
21 August 1995
Copley Receives Approval
13 February 1995
MDR: Misunderstood Drug Resistance?
5 December 1994
AMERICAN HOME HAS CONFIDENCE FOR 1993
12 April 1993
SOTALOL BEST, SAYS ARRHYTHMIA STUDY
27 April 1992
CAST EFFECTS ON ANTI-ARRHYTHMICS
20 January 1992
Showing 1-14 of 14 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
